These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 17823789)

  • 1. Renal deterioration caused by carcinogens as a consequence of free radical mediated tissue damage: a review of the protective action of melatonin.
    Gultekin F; Hicyilmaz H
    Arch Toxicol; 2007 Oct; 81(10):675-81. PubMed ID: 17823789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melatonin: reducing molecular pathology and dysfunction due to free radicals and associated reactants.
    Reiter RJ; Tan DX; Allegra M
    Neuro Endocrinol Lett; 2002 Apr; 23 Suppl 1():3-8. PubMed ID: 12019343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular diseases: protective effects of melatonin.
    Tengattini S; Reiter RJ; Tan DX; Terron MP; Rodella LF; Rezzani R
    J Pineal Res; 2008 Jan; 44(1):16-25. PubMed ID: 18078444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of oxygen toxicity by melatonin.
    Reiter RJ; Tan DX; Qi WB
    Zhongguo Yao Li Xue Bao; 1998 Nov; 19(6):575-81. PubMed ID: 10437151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential anticarcinogenic action of melatonin and other antioxidants mediated by antioxidative mechanisms.
    Karbownik M
    Neuro Endocrinol Lett; 2002 Apr; 23 Suppl 1():39-44. PubMed ID: 12019350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of Didymocarpus pedicellata on ferric nitrilotriacetate (Fe-NTA) induced renal oxidative stress and hyperproliferative response.
    Kaur G; Lone IA; Athar M; Alam MS
    Chem Biol Interact; 2007 Jan; 165(1):33-44. PubMed ID: 17140554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological utility of melatonin in reducing oxidative cellular and molecular damage.
    Reiter RJ; Tan DX; Gitto E; Sainz RM; Mayo JC; Leon J; Manchester LC; Vijayalaxmi ; Kilic E; Kilic U
    Pol J Pharmacol; 2004; 56(2):159-70. PubMed ID: 15156066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melatonin: action as antioxidant and potential applications in human disease and aging.
    Bonnefont-Rousselot D; Collin F
    Toxicology; 2010 Nov; 278(1):55-67. PubMed ID: 20417677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Free radical-mediated molecular damage. Mechanisms for the protective actions of melatonin in the central nervous system.
    Reiter RJ; Acuña-Castroviejo D; Tan DX; Burkhardt S
    Ann N Y Acad Sci; 2001 Jun; 939():200-15. PubMed ID: 11462772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melatonin relieves the neural oxidative burden that contributes to dementias.
    Reiter RJ; Tan DX; Pappolla MA
    Ann N Y Acad Sci; 2004 Dec; 1035():179-96. PubMed ID: 15681808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melatonin reduces oxidative/nitrosative stress due to drugs, toxins, metals, and herbicides.
    Reiter RJ; Korkmaz A; Paredes SD; Manchester LC; Tan DX
    Neuro Endocrinol Lett; 2008 Oct; 29(5):609-13. PubMed ID: 18987585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melatonin inhibits free radical-mediated mitochondrial-dependent hepatocyte apoptosis and liver damage induced during malarial infection.
    Guha M; Maity P; Choubey V; Mitra K; Reiter RJ; Bandyopadhyay U
    J Pineal Res; 2007 Nov; 43(4):372-81. PubMed ID: 17910606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of carbon tetrachloride-mediated apoptosis and oxidative stress by melatonin in experimental liver fibrosis.
    Ogeturk M; Kus I; Pekmez H; Yekeler H; Sahin S; Sarsilmaz M
    Toxicol Ind Health; 2008 May; 24(4):201-8. PubMed ID: 19022872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetic radical-scavenging activity of melatonin.
    Fujisawa S; Kadoma Y; Ishihara M; Shibuya K; Yokoe I
    In Vivo; 2006; 20(2):215-20. PubMed ID: 16634521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melatonin as a pharmacological agent against oxidative damage to lipids and DNA.
    Reiter RJ; Tan DX; Kim SJ; Qi W
    Proc West Pharmacol Soc; 1998; 41():229-36. PubMed ID: 9836298
    [No Abstract]   [Full Text] [Related]  

  • 16. Protective effect of melatonin on photo-damage to lysozyme.
    Zhu H; Chen S; Yao S; Wang W
    J Photochem Photobiol B; 2009 Feb; 94(2):125-30. PubMed ID: 19097803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Melatonin as an antioxidant].
    Skrzydlewska E
    Postepy Hig Med Dosw; 2001; 55(6):871-89. PubMed ID: 11875783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melatonin as a radioprotective agent: a review.
    Vijayalaxmi ; Reiter RJ; Tan DX; Herman TS; Thomas CR
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):639-53. PubMed ID: 15183467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonin defeats neurally-derived free radicals and reduces the associated neuromorphological and neurobehavioral damage.
    Reiter RJ; Tan DX; Manchester LC; Tamura H
    J Physiol Pharmacol; 2007 Dec; 58 Suppl 6():5-22. PubMed ID: 18212398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melatonin reduces oxidative damage induced by aluminium in rat kidney.
    Mahieu S; Contini Mdel C; González M; Millen N
    Toxicol Lett; 2009 Oct; 190(1):9-15. PubMed ID: 19539013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.